Be a Smart Investor
Tuesday, March 6, 2018
Dermira Inc. (DERM) Plunged To A New Low After Phase 3 Study Failed
Dermira Inc. (DERM) announced Monday morning that olumacostat glasaretil did not meet the co-primary endpoints in its two Phase 3 studies.
from RTT - Before the Bell http://ift.tt/2H9Anqs
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment